Fertility and Sterility
Volume 91, Issue 6 , Pages 2408-2413 , June 2009

How to predict implantation? No correlation between embryonic aneuploidy and soluble human leukocyte antigen G-concentrations

  • Carolyn B. Coulam, M.D.

      Affiliations

    • Rinehart Center for Reproductive Medicine, Evanston, Illinois
    • CARI Reproductive Institute, Chicago, Illinois
    • Corresponding Author InformationReprint requests: Carolyn Coulam, M.D., 2500 Ridge Ave, Suite 200, Evanston, IL 60201 (FAX: 847-869-7782).
    • ,
  • Roumen G. Roussev, M.D., Ph.D.

      Affiliations

    • CARI Reproductive Institute, Chicago, Illinois
    • ,
  • Sveltana Lerner, M.S.

      Affiliations

    • Reproductive Genetics Institute, Chicago, Illinois
    • ,
  • Zev Zlatopolsky, B.S.

      Affiliations

    • Reproductive Genetics Institute, Chicago, Illinois
    • ,
  • Yuri Ilkevitch, Ph.D.

      Affiliations

    • Reproductive Genetics Institute, Chicago, Illinois
    • ,
  • Ilan Tur-Kaspa, M.D.

      Affiliations

    • Reproductive Genetics Institute, Chicago, Illinois
    • Institute for Human Reproduction (IHR), Chicago, Illinois

Received 22 January 2008 ,Revised 31 March 2008 ,Accepted 31 March 2008.

References 

  1. Kallen B, Finnstrom O, Nygren KG, Otterblad-Olausson P. Temporal trends in multiple births after in vitro fertilization in Sweden, 1982–2001: a register study. BMJ. 2005;331:382–383
  2. van Montfoort AP, Fiddelers AA, Janssen JM, Derhaag JG, Dirksen CD, Dunselman GA, et al. In unselected patients, elective single embryo transfer prevents multiples, but results in significantly lower pregnancy rates that with double embryo transfer: a randomized controlled trial. Hum Reprod. 2006;21:338–343
  3. De Placido G, Wilding M, Strina I, Aviggi F, Alviggi C, Mollo A, et al. High outcome predictability after IVF using a combined score for zygote and embryo morphology and growth rate. Hum Reprod. 2002;17:2402–2409
  4. Munne S, Sandalinas M, Escudero T, Velilla E, Walmsley R, Sadowy S, et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online. 2003;7:91–97
  5. Verlinsky Y, Tur-Kaspa I, Cieslak J, Bernal A, Morris R, Taranissi M, et al. Preimplantation testing for chromosomal disorders improve reproductive outcome of poor prognosis patients. Reprod Biomed Online. 2005;11:219–225
  6. Roussev R, Coulam CB. Detection of soluble HLA-G levels in embryo culture media is predictive for embryo quality and successful pregnancy in IVF. Am J Reprod Immunol. 2004;51:471–472
  7. Fuzzi B, Rizzo L, Cruiscuoli I, Noci L, Melchiorri B, Scarselli E, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002;32:311–315
  8. Sher G, Keskintepe L, Fisch JD, Acacio BA, Ahlering P, Batzofin J, et al. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril. 2005;83:1410–1413
  9. Roussev RG, Coulam CB. HLA-G and its role in implantation (review). J Assist Reprod Genet. 2007;28:288–295
  10. Rijnders PM, Jansen CAM. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in vitro fertilization or intracytoplasmic sperm injection. Hum Reprod. 1998;13:2869–2873
  11. Yakin K, Balaban B, Isiklar A, Urman B. Oocyte dimorphism is not associated with aneuploidy in the developing embryo. Fertil Steril. 2007;88:811–816
  12. Rechitsky S, Kuliev A, Sharapova T, Laziuk K, Ozen S, Barsky I, et al. Preimplantation HLA typing with aneuploidy testing. Reprod Biomed Online. 2006;12:89–100
  13. Verlinsky Y. Over a decade of experience with preimplantation genetic diagnosis. Fertil Steril. 2004;82:302–303
  14. Staessen , Platteau P, Van Assche E, Michaels A, Tournaye H, Camus M, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled study. Hum Reprod. 2004;19:2849–2858
  15. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained miscarriages. Fertil Steril. 2005;83:393–397
  16. Mastenbrock S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, et al. Preimplantation genetic screening in women of advanced maternal age. N Engl J Med. 2007;357:9–17
  17. Munne S, Weier HU. Simultaneous enumeration of chromosomes 13, 18, 21, X, and Y in interphase cells for preimplantation genetic diagnosis of aneuploidy. Cytogen Cell Genet. 1996;75:263–270
  18. Gianaroli L, Magil MC, Munne S, Fiorentino A, Montanaro N, Ferraretti AP. Will preimplantation genetic diagnosis assist patients with poor prognosis to achieve pregnancy?. Hum Reprod. 1997;12:1762–1767
  19. Hu DG, Webb G, Hussey N. Aneuploidy detection in single cells using DNA array-based comparative genomic hybridization. Mol Hum Reprod. 2004;10:283–289
  20. Sohni YR, Burke JP, Dyck PJ, O'Kane DJ. Microfluidic chip-based method for genotyping microsatellites, VNTRs and insertion/deletion polymorphisms. Clin Biochem. 2003;36:35–40
  21. Munne S, Gianaroli L, Tur-Kaspa I, Magli C, Sandalinas M, Grifo J, et al. Substandard application of preimplantation genetic screening may interfere with its clinical success. Fertil Steril. 2007;88:781–784
  22. Ziebe S, Lundin K, Loft A, Bergh C, Nyboe-Andersen A, Skelleskog U, et al. FISH analysis for chromosomes 13, 16, 18, 21, 22, X and Y in all blastomeres of IVF pre-embryos from 144 randomly selected donated human oocytes and impact on pre-embryo morphology. Hum Reprod. 2003;18:2575–2581
  23. Li M, De Ugarte CM, Surrey M, Danzer H, De Cherney A, Hill DL. Fluorescence in situ hybridization reanalysis of day 6 human blastocysts diagnosed with aneuploidy on day 3. Fertil Steril. 2005;84:1395–1400
  24. Baart EB, Martini E, van den Berg I, Macklon NS, Galjaard RJH, Fauser BCJM, et al. Preimplantation genetic screening reveals a high incidence of aneuploidy and mosiacism in embryos from young women undergoing IVF. Hum Reprod. 2006;21:223–233
  25. Coulam CB, Jeyendran RS, Fiddler M, Pergament E. Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffective. J Assist Reprod Genet. 2007;24:37–41
  26. Practice Committee of the Society for Assisted Reproductive TechnologyPractice Committee of the American Society for Reproductive Medicine. Preimplantation genetic testing: a practice committee opinion. Fertil Steril. 2007;88:1497–1504
  27. Le Bouteiller P. HLA class I chromosomal region, genes, and products: facts and questions. Crit Rev Immunol. 1994;14:89–129
  28. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005;19:681–693
  29. Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertil Steril. 1966;65:997–1002
  30. Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during pre-implantation human embryo development. Proc Nat Acad Sci USA. 1996;93:161–165
  31. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Nat Acad Sci USA. 1992;89:3947–3951
  32. Munz C, Holmes N, King A, Loke YW, Colonna M, Schild H, et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med. 1997;185:385–392
  33. Soderstrom K, Corliss B, Lanier LL, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol. 1997;159:1072–1075
  34. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol. 1999;29:277–283
  35. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA. 1999;96:5674–5679
  36. Rajagopalan S, Long EO. A human histocompatability leukocyte antigen HLA-G-specific receptor expressed on all natural killer cells. J Exp Med. 1999;189:1093–1100
  37. Cantoni C, Verdiani S, Falco M, Pessino A, Conte R, Pende D, et al. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 1998;28:1980–1990
  38. Roussev RG, Ng SC, Coulam CB. Natural Killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. Am J Reprod Immunol. 2007;57:262–269
  39. van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod. 2007;13:123–133
  40. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has concentration dependent effect on the generation of an allo-CTL response. Immunology. 2000;101:191–200
  41. McIntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS. Recombinant HLA-G5 and-G6 drives U937 myelomonocytic cell production of TGF-bets-1. J Leukoc Biol. 2004;76:1220–1229
  42. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med. 1998;187:217–223
  43. Roberts CJ, Lowe CR. Where have all the conceptions gone?. [letter] Lancet. 1975;1:498–499
  44. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189–194
  45. Hoozemans DA, Schats R, Lambalk CB, Homburg R, Hompes PGA. Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reprod Biomed Online. 2004;9:692–715
  46. MacKay A, Berg CJ, Duran C, Chang J. Pregnancy-related mortality among women with multifetal pregnancies. Obstet Gynecol. 2006;107:563–568
  47. Gerris J, De Sutter P, De Neubourg D, van Royen E, Vander Elst J, Mangelschots K, et al. A real-life prospective health economic study of elective single embryo transfer versus two-embryo transfer in first IVF/ICSI cycle. Hum Reprod. 2004;19:917–923
  48. Poikkeus P, Gissler M, Unkila-Kallio L, Hyden-Granskog C, Tiitinen A. Obstetric and neonatal outcome after single embryo transfer. Hum Reprod. 2007;22:1073–1079
  49. Le Lannou D, Griveau JF, Laurent MC, Gueho A, Veron E, Morcel K. Contribution of embryo cryopreservation to elective single embryo transfer in IVF-ICSI. Reprod Biomed Online. 2006;13:368–375
  50. Donoso P, Verpoest W, Papanikolaou EG, Liebaers I, Fatemi HM, Sermon K, et al. Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate. Hum Reprod. 2007;22:1021–1025
  51. Thurin A, Hausken J, Hillensjo T, Jablonowska B, Pinborg A, Strandell A, et al. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med. 2004;351:2392–2402
  52. De Sutter OP, van der Elst P, Coetsier T, Dhont M. Single embryo transfer and multiple pregnancy rates reduction in IVF/ICSI: a 5-year appraisal. Reprod Biomed Online. 2003;6:464–469
  53. Veleva Z, Vilska S, Hyden-Granskog C, Tiitinen A, Tapanainen JS, Martikainen H. Elective single embryo transfer in women aged 36–39 years. Hum Reprod. 2006;21:2098–2102
  54. De Neubourg D, Gerris J. Single embryo transfer-state of the art. Reprod Biomed Online. 2003;7:615–622
  55. Papanikolaou EG, Camus M, Kolibianakis EM, van Landuyt L, van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst stage versus single cleavage state embryos. N Engl J Med. 2006;354:1139–1146
  56. Gleicher N, Barad D. The relative myth of elective single embryo transfer. Hum Reprod. 2006;21:1337–1344
  57. Kjellberg AT, Carlsson P, Bergh C. Randomized single versus double embryo transfer: obstetric and pediatric outcome and a cost-effective analysis. Hum Reprod. 2006;21:210–216
  58. Callahan TL, Hall JE, Ettner SL, Christianson CL, Greene MF, Crowley WF. The economic impact of multiple gestation pregnancies and the contribution of assisted reproduction techniques to their incidence. N Engl J Med. 1994;331:244–249
  59. Edwards RG, Brody SA. Principles and practice of assisted human reproduction. Philidelphia: WB Saunders; 1995;

 C.B.C. has nothing to disclose. R.G.R. has nothing to disclose. S.L. has nothing to disclose. Z.Z. has nothing to disclose. Y.I. has nothing to disclose. I.T-K. has nothing to disclose.

 Supported in part by an independent research grant from Ferring Pharmaceutical Company.

PII: S0015-0282(08)00780-2

doi: 10.1016/j.fertnstert.2008.03.081

Fertility and Sterility
Volume 91, Issue 6 , Pages 2408-2413 , June 2009

Article Tools

* Image Usage & Resolution